Arlot ME. Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: comparison with normal postmenopausal women. Osteoporos Int 1990;1(1):41-9.
Balena R. Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone. Osteoporos Int 1998;8(5):428-35.
Black DM. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356(18):1809-22.
Bravenboer N. Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis. Osteoporos Int 1999;9:489-93.
Brown JP. Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis. J Clin Endocrinol Metab 1987;64:954-9.
Chapurlat RD. Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study. J Bone Miner Res 2007;22(10):1502-9.
Chavassieux PM. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 1997;100(6):1475-80.
Clarke BL. Changes in quantitative bone histomorphometry in aging healthy men. J Clin Endocrinol Metab 1996;81(6):2264-70.
Coen G. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. Nephrol Dial Transplant 1996;11(5):813-9.
Dahl E. Histomorphometric analysis of normal bone from the iliac crest of Norwegian subjects. Bone Miner 1988;3(4):369-77.
Eastell R. Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 1988;67:741-8.
Eriksen EF. Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition. Metab Bone Dis Relat Res 1984;5(5):243-52.
Eriksen EF. Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. Bone 2002;31:620-5.
Garcia Carasco M. Decreased bone formation in osteoporotic patients compared with age-matched controls. Calcif Tissue Int 1989;44(3):173-5.
Garcia-Carrasco M. Osteocalcin and bone morphometric parameters in adults without bone disease. Calcif Tissue Int 1988;42(1):13-7.
Glorieux FH. Normative data for iliac bone histomorphometry in growing children. Bone 2000;26:103-9.
Han ZH. Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss. J Bone Miner Res 1997;12:498-508.
Hodsman AB. Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: evidence for de novo bone formation on quiescent cancellous surfaces. Bone 1993;14(3):523-7.
Hodson EM. Quantitative bone histology in children with chronic renal failure. Kidney Int 1982;21:833-9.
Jiang Y. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 2003;18(11):1932-41.
Keshawarz NM. The label escape error: comparison of measured and theoretical fraction of total bone-trabecular surface covered by single label in normals and patients with osteoporosis. Bone 1986;7(2):83-7.
Kimmel DB. A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects. Bone Miner 1990;11:217-35.
Mawer EB. The relationship between serum vitamin D concentrations and in vivo tetracycline labeling of osteoid in crush fracture osteoporosis. Calcif Tissue Int 1991;48(2):78-81.
Melsen F. Histomorphometric analysis of normal bone from the iliac crest. Acta Pathol Microbiol Scand [A] 1978;86(1):70-81.
Ott SM. Bone formation periods studied with triple tetracycline labels in women with postmenopausal osteoporosis. J Bone Miner Res 1993;8:443-50.
Ott SM. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 1989;110:267-74.
Ott SM. Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women. J Bone Miner Res 2002;17:341-8.
Ott SM. Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 1994;78:968-72.
Parfitt AM. Effects of ethnicity and age or menopause on osteoblast function, bone mineralization, and osteoid accumulation in iliac bone. J Bone Miner Res 1997;12(11):1864-73.
Parfitt AM. Relations between histologic indices of bone formation: implications for the pathogenesis of spinal osteoporosis. J Bone Miner Res 1995;10(3):466-73.
Parisien M. Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women. J Bone Miner Res 1997;12(6):948-57.
Recker R. Trabecular bone microarchitecture after alendronate treatment of osteoporotic women. Curr Med Res Opin 2005;21(2):185-94.
Recker RR. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res 2008;23(1):6-16.
Recker RR. Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res 1988;3(2):133-44.
Recker RR. Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study. Osteoporos Int 2004;15:231-7. Epub 2004 Jan 16.
Rehman MT. Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 1994;47(6):529-34.
Reid IR. Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies. J Bone Miner Res 2010;25(10):2256-65.
Sherrard DJ, Maloney N, Ott SM. unpublished results. 1983.
Steiniche T. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone 1989;10(5):313-20.
Stepan JJ. Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone 2007;41(3):378-85.
Storm T. Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis. J Bone Miner Res 1993;8(2):199-208.
Tanizawa T. Changes in cortical width with bone turnover in the three different endosteal envelopes of the ilium in postmenopausal osteoporosis. Bone 1999;25(4):493-9.
Thamsborg G. Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis. Bone 1996;18(2):207-12.
Vedi S. Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects. Metab Bone Dis Relat Res 1983;5(2):69-74.